Scarless Surgery: Clinical Indications for Transoral Endocrine Surgery and Implications for Pathologists

Jordan M Broekhuis; Benjamin C James; Raymon H Grogan

doi:10.1016/j.path.2022.10.002

Scarless Surgery: Clinical Indications for Transoral Endocrine Surgery and Implications for Pathologists

Surg Pathol Clin. 2023 Mar;16(1):163-166. doi: 10.1016/j.path.2022.10.002. Epub 2022 Dec 9.

Authors

Jordan M Broekhuis¹, Benjamin C James¹, Raymon H Grogan²

Affiliations

¹ Harvard Medical School, Boston, MA, USA; Department of Surgery, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA.
² Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 7200 Cambridge Street, 7th Floor, Room A07-103, Houston, TX 77030, USA. Electronic address: rgrogan@bcm.edu.

PMID: 36739163
DOI: 10.1016/j.path.2022.10.002

Abstract

Transoral endocrine surgery (TES) is a scarless approach to thyroidectomy and parathyroidectomy for well-selected patients. Criteria for the TES approach to thyroidectomy include thyroid diameter less than or equal to 10 cm, benign nodule less than or equal to 6 cm, or confirmed or suspected malignant nodule less than or equal to 2 cm. Although fragmentation of surgical specimens has been reported in TES, additional studies are needed to evaluate the implications of TES on pathologic examination.

Keywords: Endocrine surgery; Remote access surgery; Thyroid cancer; Transoral endocrine surgery; Transoral endoscopic thyroidectomy vestibular approach.

Publication types

Review

MeSH terms

Humans
Pathologists*
Thyroid Gland
Thyroidectomy*